Morningstar

PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
ascopubs.org

Potential of urine liquid biopsy in detecting of clinically relevant genomic alterations in advanced genitourinary cancers.

Assessment of ctDNA detection in prostate cancer using a 6-base epigenomics and fragmentomics approach. GLP-1 receptor agonists vs 5-alpha reductase inhibitors for prostate cancer primary prevention ...
STAT

MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them

Pre-biopsy MRI is standard outside the U.S., but the latest data show such scans were done in only about a third of U.S.
Medical Xpress

AI tool can read prostate MRIs to help decide who needs a biopsy

Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently read X-ray images and detect bone fractures, or assess cancer tumors in both ...
ascopubs.org

Predictive capability of combining ExoDx (EPI) and pre-biopsy prostate MRI in detecting clinically significant prostate cancer in African American men.

Inherited risk for prostate cancer (PCa): Following the natural history of men with increased genetic risk using multiparametric MRI (mpMRI).
Medscape

Is MRI Alone Reliable for Prostate Cancer Monitoring?

In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...